Stay updated with breaking news from Priority Review Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juventas Cell Therapy Ltd. announces China National Medical Product Administration (NMPA) has approved its New Drug Application (NDA) for Inatic...
Press ReleaseNicox Provides Second Quarter 2023 Financial and Business Highlights Net revenue1 of €0.9 million for the second quarter of 2023 Cash...
Press ReleaseNicox's Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox's partner, Ocumension Therapeutics, announced on April